Health Care · Pharmaceutical Preparations

SVRA Savara Inc SEC Filings & Insider Trading Activity 2026

company
CIK 1160308132 filings
Russell 2000

SVRA at a glance

Savara Inc (SVRA, SEC CIK 1160308) filed its latest 10-K annual report on March 13, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on June 8, 2026 and Form 4 insider filings as recently as September 25, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • As of September 30, 2026, 25 institutional investment managers tracked by SignalX reported holding Savara Inc (SVRA) shares worth $188.7 million in 13F-HR filings.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
25 funds
$188.7M · −1 vs prior quarter
Latest 8-K
Jun 8, 2026
Item 5.03 · Item 5.07 · Item 5.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material risk-factor changes from the December 31, 2025 Form 10-K
  • Carried-forward business risk: undisclosed or currently immaterial risks could materially adversely affect results
  • Carried-forward financial risk: business condition and future results remain subject to material adverse impacts from disclosed SEC filing risks

Management Discussion & Analysis

  • No product revenue; net loss $43.0M vs $29.6M YoY
  • Operating margin not applicable, loss from operations $43.5M vs $30.3M YoY
  • R&D $24.9M, up 21.1%; G&A $18.5M, up 92.6%, worst cost increase
  • Cash and equivalents $29.8M, short-term investments $99.8M at September 30
  • Operating cash use $105.3M; additional capital may be needed for regulatory approval and commercialization

AI summary of the SVRA 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Jun 8, 2026Full analysis →

Item 5.03: Amendments to Articles of Incorporation or Bylaws

  • Authorized common shares doubled from 300 million to 600 million
  • Stockholder-approved amendment effective June 4, 2026 upon Delaware filing

Item 5.07: Submission of Matters to a Vote of Security Holders

  • All six director nominees elected, with An van Es-Johansson receiving 158.7M votes for
  • Authorized common shares doubled from 300M to 600M, expanding potential equity-financing capacity

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Stockholders approved 18.9 million additional shares under Savara’s 2024 incentive plan, increasing potential equity dilution
  • CFO and Chief Administrative Officer David Lowrance resigns July 15, 2026, citing health reasons
Filed Mar 13, 2026Full analysis →

Item 1.01: Entry into a Material Definitive Agreement

  • HQ relocation to Yardley, PA (19 W. College Ave); ~10,795 sq ft leased from ML7 Yardley Partners
  • Lease term July 1, 2026 – Dec 1, 2031 with 5-year renewal option

AI summaries of SVRA 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for SVRA

Don't miss the next SVRA filing

  • Alerts as it files. A push when SVRA files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut SVRA, by share count.
  • Ask anything. An AI agent that reads every SVRA filing and answers with sources.

SVRA alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Parker Braden C.FSep 24, 2026$5.07
Lutz Robert MatthewAJul 15, 2026-
Lutz Robert MatthewAJul 15, 2026-
Lowrance David LMJun 22, 2026$4.45
Lowrance David LMJun 22, 2026$1.51
Lowrance David LFJun 22, 2026$5.50
Lowrance David LMJun 22, 2026$1.11
Lowrance David LFJun 22, 2026$5.50

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Operating Income-$60.0M-$103.2M-$123.5M
Net Income-$54.7M-$95.9M-$118.8M
Balance Sheet
Total Assets$177.6M$212.9M$253.4M
Equity$140.4M$171.4M$203.1M
ROE-39.0%-55.9%-58.5%
Per Share
EPS$-0.33$-0.48$-0.53
Cash Flow
Operating CF-$51.1M-$89.1M-$101.0M
CapEx-$25K$22K

Source: XBRL data in Savara Inc (SVRA)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate SVRA share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
SVRA shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202625$188.7M
Q2 202626$222.8M
Q1 202626$196.4M
Q4 202520$209.2M
Q3 202522$94.7M
Q2 202521$56.0M
Q1 202519$45.6M
Q4 202416$52.2M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 175 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

SVRA filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
10-QNov 9, 2026Analysis
4Sep 25, 2026--
10-QAug 11, 2026Analysis
4Jul 24, 2026--
4Jun 22, 2026--
8-KJun 8, 2026Analysis
10-QMay 12, 2026Analysis
4Mar 20, 2026--
8-KMar 13, 2026Analysis-
10-KMar 13, 2026-
4Feb 17, 2026-
8-KJan 27, 2026-
SC 13GJan 21, 2026-
8-KJan 9, 2026-
4Dec 19, 2025-
4Dec 16, 2025-
4Dec 16, 2025-
4Dec 16, 2025-
4Dec 16, 2025-
4Dec 16, 2025-
4Dec 11, 2025-
4Dec 11, 2025-
4Dec 11, 2025-
4Dec 11, 2025-
4Dec 11, 2025-

Related Health Care companies

All Health Care →

SVRA SEC filings: frequently asked questions

Which institutions hold SVRA stock?

As of September 30, 2026, the largest Savara Inc (SVRA) holders among the 13F filers tracked by SignalX were BlackRock ($65.0 million), Vanguard Capital Management LLC ($41.9 million), State Street Corp ($34.3 million), D.E. Shaw & Co ($12.4 million), Vanguard Portfolio Management LLC ($7.9 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What did SVRA report in its latest 8-K?

Savara Inc (SVRA) filed an 8-K on June 8, 2026 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 5.07 (Submission of Matters to a Vote of Security Holders) and Item 5.02 (Departure/Appointment of Directors or Principal Officers). Authorized common shares doubled from 300 million to 600 million.

What are the latest SVRA SEC filings?

Savara Inc (SVRA) filed its latest 10-K annual report on March 13, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on June 8, 2026 and a Form 4 insider filing on September 25, 2026.

What is SVRA's SEC CIK number?

Savara Inc (SVRA)'s SEC Central Index Key (CIK) is 1160308. EDGAR lists every SVRA filing under that number.

Ask anything about SVRA

The research agent reads SVRA's filings, financials, insider trades and 13F holders, then answers with sources.